The Anti-Saccharomyces Cerevisiae Antibody Assay in a Province-Wide Practice: Accurate in Identifying Cases of Crohn’s Disease and Predicting Inflammatory Disease

Brinderjit Kaila; Kenneth Orr; Charles N Bernstein

doi:10.1155/2005/147681

Canadian Journal of Gastroenterology (Jan 2005)

The Anti-Saccharomyces Cerevisiae Antibody Assay in a Province-Wide Practice: Accurate in Identifying Cases of Crohn’s Disease and Predicting Inflammatory Disease

Brinderjit Kaila,
Kenneth Orr,
Charles N Bernstein

Affiliations

Brinderjit Kaila: Department of Internal Medicine, University of Manitoba, Canada
Kenneth Orr: Department of Laboratory Medicine, University of Manitoba and the Saint Boniface General Hospital Immunology Laboratory, Canada
Charles N Bernstein: Department of Internal Medicine, University of Manitoba, Canada

DOI: https://doi.org/10.1155/2005/147681
Journal volume & issue: Vol. 19, no. 12
pp. 717 – 721

Abstract

Read online

OBJECTIVE: To determine the utility of the anti-Saccharomyces cerevisiae antibody (ASCA) ELISA test developed in Manitoba in 2001 in a population-wide sample referred from physicians across Manitoba in their investigation of patients with gastrointestinal symptoms.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal